eCARTv5 Clinical Deterioration Suite (eCART) vs Rounds AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Rounds AI

by Rounds AI

AI Verdict

Tool A (eCARTv5) focuses on proactive patient risk assessment and early warning for clinical deterioration in hospitalized adults, integrating directly with EHRs to guide care pathways. Tool B (Rounds AI) acts as an evidence-based clinical AI assistant, providing instant, cited answers to a broad range of clinical questions, including drug interactions and diagnostics. While both offer clinical decision support, eCARTv5 is geared towards continuous patient monitoring and deterioration prediction, whereas Rounds AI is a reference tool for immediate, evidence-backed answers to clinician queries.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an AI-powered early warning system to continuously monitor hospitalized adult patients for clinical deterioration (death or ICU transfer). It's ideal for institutions seeking to integrate real-time risk assessment directly into their EHR workflows and leverage embedded clinical pathways for proactive care guidance. The tool is designed to minimize false alarms and reduce clinician workload while providing continuous patient risk assessment.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Rounds AI if…

Choose Rounds AI if clinicians require an evidence-linked, citation-first AI assistant for instant, reliable answers to clinical questions, including medication safety and drug interaction checks. This tool is best suited for individual practitioners or healthcare teams who prioritize verifiable information grounded in guidelines, peer-reviewed literature, and FDA prescribing information, accessible via web or iOS.

View Rounds AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Rounds AI
Pricing	Contact vendor for tailored quote.	Paid
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud, iOS App
FDA Status	1 AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

AgileMD's eCART is praised for its seamless EHR integration and intuitive user interface, streamlining workflows and reducing clinician workload. Rounds AI is designed for quick, evidence-based answers with citations, offering web and iOS access with synchronized history. Both aim to enhance user experience by providing critical information efficiently, though in different contexts.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared SaMD that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. This direct impact on patient outcomes through early warning and intervention provides significant clinical value. Rounds AI, while providing evidence-based answers and drug interaction checks, serves more as a clinical AI assistant rather than a direct intervention tool for patient deterioration.

Pricing & Value

Rounds AI

Rounds AI offers transparent, publicly listed pricing with weekly, monthly, and enterprise options, making its cost structure clear to potential users. AgileMD's eCART requires contacting the vendor for a tailored quote, which, while common for enterprise solutions, lacks initial transparency.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCART is designed for cloud-based SaaS deployment, integrated directly into EHR systems, and has a proven track record with over 400 hospitals and 4.4 million patient encounters. Its FDA clearance, HIPAA compliance, and BAA availability further solidify its enterprise readiness for large-scale healthcare systems. Rounds AI, while HIPAA compliant and cloud-based, appears to be more geared towards individual clinicians or smaller group practices with its iOS app and subscription model, and lacks the extensive enterprise deployment metrics of AgileMD.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 leverages AI and machine learning to provide continuous, real-time predictive analytics for clinical deterioration, integrating up to 97 variables for early warning and risk stratification. This proactive, predictive capability for critical care is a significant innovation in patient safety. Rounds AI's innovation lies in its evidence-linked, citation-first approach to providing instant clinical answers, which is valuable but less focused on novel predictive analytics for patient outcomes.

Support & Docs

Tie

Both tools are designed to integrate into clinical workflows, implying a level of support for implementation and ongoing use. However, specific details regarding the breadth and depth of their support services and documentation are not extensively detailed in the provided information or public web searches. Therefore, it is difficult to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Rounds AI
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Rounds AI
Company	AgileMD	Rounds AI
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Evidence-linked, citation-first clinical AI assistant that provides up-to-date, citation-backed answers grounded in guidelines, peer-reviewed literature, and FDA prescribing information for medication safety and drug interaction checks.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	Evidence-based answers with citations, Instant answers to clinical questions, Verifiable citations from guidelines, trials, and FDA labels, Follow-up conversations with context retention, HIPAA-aware design, Drug and interaction checks, Web and iOS access with synchronized history, Covers diagnostics, therapeutics, dosing, and guideline nuances
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Rounds AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

eCARTv5 is designed for deep EHR integration, leveraging up to 97 real-time variables from the EHR to continuously assess patient risk and embed clinical pathways for care guidance. Rounds AI, while also cloud-based and offering an iOS app, focuses on providing instant, evidence-based answers to clinical questions and performing drug interaction checks, suggesting a workflow where clinicians actively query the system for information rather than it continuously monitoring patient data.

What is the accuracy and sensitivity of eCARTv5 in predicting clinical deterioration?

eCARTv5 has demonstrated high accuracy in predicting clinical deterioration, with an AUROC of 0.834 in retrospective validation and sustained performance during prospective validation across diverse patient demographics and clinical conditions. It was found to outperform other early warning scores like MEWS, NEWS, and eCARTv2.

How do these tools support different medical specialties?

eCARTv5 is primarily geared towards critical care, emergency medicine, and hospital medicine, focusing on hospitalized adult patients at risk of deterioration. Rounds AI is broader, supporting family medicine, hospital medicine, and internal medicine by providing evidence-based answers for a wide range of clinical questions, including diagnostics, therapeutics, dosing, and guideline nuances.

What kind of audit trail features do these tools offer for accountability and review?

While the provided information does not explicitly detail the audit trail features for either tool, robust audit trails in clinical imaging systems typically involve automatically generated, time-stamped records linked to authenticated users, capturing all data creation, modification, and deletion to ensure data integrity and regulatory compliance.

What are the considerations for rolling out these tools across multiple healthcare sites?

eCARTv5's validation across 21 hospitals and nearly two million hospitalizations suggests its suitability for multi-site rollouts, with demonstrated consistent accuracy across diverse geographies, ages, races, and medical conditions. Rounds AI's cloud and iOS app deployment model offers flexibility for multi-site access, but specific multi-site rollout considerations beyond technical deployment are not detailed.